Your personal AI career agent
Medical leadership for Phase 3 trial unblinding and data readout in immunology therapies. MD with 3-5+ years late-stage biotech/pharma experience and Phase 3 trial involvement required. Stock option program participation, Wellpass, OpenUp.
Requirements
- Medical Degree (MD), ideally with neurology training/clinical background, or advanced science/related degree
- 3-5+ years experience in biotech/pharma or academic clinical research (late-stage trials)
- Previous involvement in Phase 3 clinical trials
- Expertise in Multiple Sclerosis, advantageous scientific understanding of disease mechanisms/clinical development pathways
- Solid knowledge of GCP and international regulatory requirements (FDA, EMA)
- Experience in assessing risks/opportunities/implications in late-stage drug development
- Ability to lead and collaborate in cross-functional/matrix teams
- Excellent communication skills and strategic mindset
- Native-level English proficiency
Tasks
- Lead unblinding, data review, and readout of Phase 3 trials
- Analyze and interpret comprehensive trial data
- Provide medical leadership for Clinical Study Reports
- Support pre-NDA regulatory activities (FDA, EMA)
- Communicate clinical outcomes and study rationale clearly
- Collaborate with medical advisory board and key investigators
- Represent the program at scientific and medical conferences
- Collaborate with NDA preparation team
- Shape key messages, clinical summaries, and data presentations for NDA
- Evaluate high-level Phase 3 results
- Support global registration and reimbursement strategies
- Support scientific publications
- Provide hands-on medical monitoring for Phase 3 trials
- Review activities during data cleaning
- Partner with Pharmacovigilance on medical assessment of safety cases
- Review and prepare narratives for serious adverse events (SAEs)
- Lead interactions with regulatory authorities
- Ensure alignment on clinical evidence and program strategy
Work Experience
- 3 - 5 years
Education
- Bachelor's degreeOR
- Master's degree
Languages
- English – Native
Benefits
Career Advancement
- Professional growth opportunities
Startup Environment
- Dynamic, flexible, and innovative working environment
Competitive Pay
- Stock option program participation
Healthcare & Fitness
- Wellpass
Mental Health Support
- OpenUp
Not a perfect match?
- Immunic AGFull-timeOn-siteSeniorGräfelfing
- Alexion
Medical Science Liaison Manager, Neurology(m/w/x)
Full-timeOn-siteSeniorMünchen - Scholar Rock
Country Medical Director(m/w/x)
Full-timeOn-siteSeniorFrankfurt am Main, München - BioNTech SE
(Senior-) Director Clinical Development(m/w/x)
Full-timeOn-siteSeniorMainz, München - Regeneron GmbH
Country Medical Director(m/w/x)
Full-timeOn-siteManagementMünchen
Medical leadership for Phase 3 trial unblinding and data readout in immunology therapies. MD with 3-5+ years late-stage biotech/pharma experience and Phase 3 trial involvement required. Stock option program participation, Wellpass, OpenUp.
Requirements
- Medical Degree (MD), ideally with neurology training/clinical background, or advanced science/related degree
- 3-5+ years experience in biotech/pharma or academic clinical research (late-stage trials)
- Previous involvement in Phase 3 clinical trials
- Expertise in Multiple Sclerosis, advantageous scientific understanding of disease mechanisms/clinical development pathways
- Solid knowledge of GCP and international regulatory requirements (FDA, EMA)
- Experience in assessing risks/opportunities/implications in late-stage drug development
- Ability to lead and collaborate in cross-functional/matrix teams
- Excellent communication skills and strategic mindset
- Native-level English proficiency
Tasks
- Lead unblinding, data review, and readout of Phase 3 trials
- Analyze and interpret comprehensive trial data
- Provide medical leadership for Clinical Study Reports
- Support pre-NDA regulatory activities (FDA, EMA)
- Communicate clinical outcomes and study rationale clearly
- Collaborate with medical advisory board and key investigators
- Represent the program at scientific and medical conferences
- Collaborate with NDA preparation team
- Shape key messages, clinical summaries, and data presentations for NDA
- Evaluate high-level Phase 3 results
- Support global registration and reimbursement strategies
- Support scientific publications
- Provide hands-on medical monitoring for Phase 3 trials
- Review activities during data cleaning
- Partner with Pharmacovigilance on medical assessment of safety cases
- Review and prepare narratives for serious adverse events (SAEs)
- Lead interactions with regulatory authorities
- Ensure alignment on clinical evidence and program strategy
Work Experience
- 3 - 5 years
Education
- Bachelor's degreeOR
- Master's degree
Languages
- English – Native
Benefits
Career Advancement
- Professional growth opportunities
Startup Environment
- Dynamic, flexible, and innovative working environment
Competitive Pay
- Stock option program participation
Healthcare & Fitness
- Wellpass
Mental Health Support
- OpenUp
About the Company
Immunic AG
Industry
Pharmaceuticals
Description
Immunic Therapeutics is a biotechnology company developing immunology therapies for chronic inflammatory and autoimmune diseases.
Not a perfect match?
- Immunic AG
Senior Medical Director(m/w/x)
Full-timeOn-siteSeniorGräfelfing - Alexion
Medical Science Liaison Manager, Neurology(m/w/x)
Full-timeOn-siteSeniorMünchen - Scholar Rock
Country Medical Director(m/w/x)
Full-timeOn-siteSeniorFrankfurt am Main, München - BioNTech SE
(Senior-) Director Clinical Development(m/w/x)
Full-timeOn-siteSeniorMainz, München - Regeneron GmbH
Country Medical Director(m/w/x)
Full-timeOn-siteManagementMünchen